Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans

Authors: Leuva, Harshraj, Zhou, Mengxi, Brau, Norbert, Brown, Sheldon T., Mundi, Prabhjot, Rosenberg, Ta-Chueh Melody, Luhrs, Carol, Bates, Susan E., Park, Yeun-Hee Anna, Fojo, Tito

Source: In Seminars in Oncology October 2022 49(5):363-370

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

Authors: Pinato, David J., Kaneko, Takahiro, Forner, Alejandro, Minguez, Beatriz, Giannini, Edoardo Giovanni, Díaz, Alba, Grillo, Federica, Mauri, Francesco, Pria, Alessia Dalla, Goldin, Robert D., Casagrande, Edoardo, Cacciato, Valentina, Akarca, Ayse, Marafioti, Teresa, Bhoori, Sherrie, Bower, Mark, Brau, Norbert, Mazzaferro, Vincenzo

Source: Journal of hepatology. 73(S1):S375-S375

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120841103.0x000001&indx=1&recIds=ETOCvdc_100120841103.0x000001

Safety and Efficacy of Glecaprevir/Pibrentasvir in Adults with Chronic Hepatitis C Virus Infection Genotype 1 and 6 and Chronic Kidney Disease: An Integrated Analysis

Authors: Pol, Stanislas, Pockros, Paul J., Pugatch, David, Brau, Norbert, Landis, Charles, Elkhashab, Magdy, Sasadeusz, Joe, Tran, Albert, Hu, Yiran, Kosloski, Matthew P., Mensa, Federico

Source: Gastroenterology. 152(5):S1062-S1063

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100054015507.0x000001&indx=1&recIds=ETOCvdc_100054015507.0x000001

SOF/VEL/VOX Results in High SVR12 Rates when Administered for 12 Weeks in Daa-Experienced Patients or for 8 Weeks in Daa-Naïve Patients: An Integrated Analysis of the POLARIS-1, POLARIS-2, POLARIS-3 and POLARIS-4 Studies

Authors: Flamm, Steven L., Roberts, Stuart, Cooper, Curtis L., Lawitz, Eric, Reddy, K. Rajender, Thompson, Alexander, Zeuzem, Stefan, Jacobson, Ira M., Ruane, Peter J., Mehta, Swarup S., Hyland, Robert H., Stamm, Luisa, Han, Lingling, Brainard, Diana, Brau, Norbert, Asselah, Tarik, Willems, Bernard, Bourliere, Marc, Foster, Graham R., Gane, Edward, Manns, Michael, Gordon, Stuart C., Kowdley, Kris V.

Source: Gastroenterology. 152(5):S1057-S1058

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100054015345.0x000001&indx=1&recIds=ETOCvdc_100054015345.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

THU472 - Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

Authors: Pinato, David J., Kaneko, Takahiro, Forner, Alejandro, Minguez, Beatriz, Giannini, Edoardo Giovanni, Díaz, Alba, Grillo, Federica, Mauri, Francesco, Pria, Alessia Dalla, Goldin, Robert D., Casagrande, Edoardo, Cacciato, Valentina, Akarca, Ayse, Marafioti, Teresa, Bhoori, Sherrie, Bower, Mark, Brau, Norbert, Mazzaferro, Vincenzo

Source: In Journal of Hepatology August 2020 73 Supplement 1:S375-S375

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

510 - Safety and Efficacy of Glecaprevir/Pibrentasvir in Adults with Chronic Hepatitis C Virus Infection Genotype 1 and 6 and Chronic Kidney Disease: An Integrated Analysis

Authors: Pol, Stanislas, Pockros, Paul J., Pugatch, David, Brau, Norbert, Landis, Charles, Elkhashab, Magdy, Sasadeusz, Joe, Tran, Albert, Hu, Yiran, Kosloski, Matthew P., Mensa, Federico

Source: In Gastroenterology April 2017 152(5) Supplement 1:S1062-S1063

424 - SOF/VEL/VOX Results in High SVR12 Rates when Administered for 12 Weeks in Daa-Experienced Patients or for 8 Weeks in Daa-Naïve Patients: An Integrated Analysis of the POLARIS-1, POLARIS-2, POLARIS-3 and POLARIS-4 Studies

Authors: Flamm, Steven L., Roberts, Stuart, Cooper, Curtis L., Lawitz, Eric, Reddy, K. Rajender, Thompson, Alexander, Zeuzem, Stefan, Jacobson, Ira M., Ruane, Peter J., Mehta, Swarup S., Hyland, Robert H., Stamm, Luisa, Han, Lingling, Brainard, Diana, Brau, Norbert, Asselah, Tarik, Willems, Bernard, Bourliere, Marc, Foster, Graham R., Gane, Edward, Manns, Michael, Gordon, Stuart C., Kowdley, Kris V.

Source: In Gastroenterology April 2017 152(5) Supplement 1:S1057-S1058

Su1415 The Tolerability of Sof/VEL for 12 Weeks in >1000 Patients Treated in the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies: An Integrated Safety Analysis

Authors: Shiffman, Mitchell L., Brau, Norbert, Bourgeois, Stefan, Mathurin, Philippe, Thuluvath, Paul J., Fessel, W Jeffrey, Ryder, Stephen, Gerken, Guido, Foster, Graham R., Jacobson, Ira M., Liu, Lin, Ding, Xiao, McNally, John, Osinusi, Anu, Grabowski, Chester, Moon, Scott, Brainard, Diana, Subramanian, Mani

Source: In Gastroenterology April 2016 150(4) Supplement 1:S1093-S1093

499 Ribavirin-Free Regimen With Velpatasvir and Sofosbuvir is Associated With High Efficiency and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From ASTRAL-2 and 3 Clinical Trials

Authors: Younossi, Zobair M., Stepanova, Maria, Sulkowski, Mark, Foster, Graham R., Reau, Nancy, Mangia, Alessandra, Patel, Keyur, Brau, Norbert, Roberts, Stuart K., Afdhal, Nezam H., Nader, Fatema, Hunt, Sharon

Source: In Gastroenterology April 2016 150(4) Supplement 1:S1035-S1035

Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.

Authors: Cozen, Myrna, Ryan, James, Shen, Hui, Cheung, Ramsey, Kaplan, David, Pocha, Christine, Brau, Norbert, Aytaman, Ayse, Schmidt, Warren, Pedrosa, Marcos, Anand, Bhupinderjit, Chang, Kyong-Mi, Morgan, Timothy, Monto, Alexander, Cozen, Myrna L, Ryan, James C, Kaplan, David E, Schmidt, Warren N, Anand, Bhupinderjit S

Source: Digestive Diseases & Sciences; Jun2016, Vol. 61 Issue 6, p1744-1756, 13p

Subject Terms: INTERFERON alpha, HEPATITIS C treatment, HEPATITIS C, CIRRHOSIS of the liver, COHORT analysis, PATIENTS, THERAPEUTICS, THERAPEUTIC use of proteins, LONGITUDINAL method, PROTEINS, RESEARCH funding, RIBAVIRIN, PROPORTIONAL hazards models

Geographic Terms: UNITED States

Company/Entity: UNITED States. Dept. of Veterans Affairs

Tu2038 All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

Authors: Jacobson, Ira M., Marcellin, Patrick, Mangia, Alessandra, Kwo, Paul Y., Foster, Graham, Buti, Maria, Brau, Norbert, Muir, Andrew J., Yang, Jenny C., Mo, Hongmei, Ding, Xiao, Pang, Phil, Symonds, William T., McHutchison, John G., Zeuzem, Stefan, Afdhal, Nezam H.

Source: In Gastroenterology May 2014 146(5) Supplement 1:S

This result is not displayed to guests.
Login for full access.